Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$20M
1 round on record
Latest round
$20M
Seed · Sep 2026 · this month
Backers
1
Compound
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 17 Raised a round Seed $20M · led by Quiet Capital · YahooFinance
Funding rounds
RoundDateAmountInvestorsSource
Seed Sep 2026 $20M Quiet Capital lead, Gradient, Haystack, Compound YahooFinance
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Dream3D is a software startup developing frontier AI models.
ConceptionVenture round $50k · 2 yr ago • Founded 2018 • 11-50 employees • 4 roles
Conception combines stem cell biology and engineering to create new possibilities for having children.
Boltz14 roles
Build better molecules with frontier AI models. With AI, we help every scientist reshape biology.
HalluminateFounded 2024 • 51-200 employees • 7 roles
Halluminate builds RL environments for financial services — computer-use and tool-use gyms that train frontier AI models on real investment…
PheironVenture round $4.2M · 16 mo ago • Founded 2023 • 11-50 employees
Pheiron is an applied research lab building models to predict which drug programs will succeed in humans.
NoetikSeed $14M · 3 yr ago • Founded 2022 • 11-50 employees
Frontier AI for Human Biology. Click to read NOETIK, a Substack publication with thousands of subscribers.

Overview

Connect with Our Team. Polyphron trains frontier AI models to manufacture and simulate donor-diverse human tissues to create the critical verification substrate for human biology.

News

News YahooFinance 19 days ago
Polyphron Raises $20M to Build Physical Verification Layer for AI-Driven Biology
NEW YORK, September 17, 2026--Polyphron, a company building artificial human biology to transform drug development and treat disease, announced $20M in seed financing led by Quiet Capital, with participation from Gradient, Haystack, and Compound. Polyphro
Read more
Report
News PRNewswire 6 months ago
PRN_FinancialWrapper
PRN_FinancialWrapper
Read more
Report
News PRNewswire 9 months ago
PRN_FinancialWrapper
PRN_FinancialWrapper
Read more
Report

Financials

Total raised
$20M
Latest round
Seed
Funding rounds
1
Funding rounds
Round Announced Amount
Seed 2026 $20M Details